Filing Details
- Accession Number:
- 0001127602-23-025798
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-12 16:01:18
- Reporting Period:
- 2023-10-10
- Accepted Time:
- 2023-10-12 16:01:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1062822 | Lexicon Pharmaceuticals Inc. | LXRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1053890 | Raymond Debbane | 2445 Technology Forest Blvd. 11Th Floor The Woodlands TX 77381 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-10-10 | 508,306 | $1.14 | 849,153 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-10-11 | 342,874 | $1.08 | 1,192,027 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-10-12 | 148,820 | $1.03 | 1,340,847 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,451,204 | Indirect | By Invus US Partners LLC |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $1.09 to $1.19 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $1.06 to $1.12 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $1.02 to $1.07 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
Billionaire Hedge Funds
